Isotype Control Antibodies
AFP113-Tirzepatide
0102030405
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
The dual-receptor pharmacology of Tirzepatide is particularly effective for weight loss due to its integrated action on the brain and adipose tissue. While the GLP-1 component drives satiety and delays gastric emptying, the GIP component is thought to enhance insulin sensitivity and potentially modulate lipid metabolism within white adipose tissue. This multifaceted approach leads to significant improvements in metabolic health, providing a comprehensive strategy for managing obesity and Type 2 diabetes.
Catalog Number |
AFP113 |
Product Name |
AFP113-Tirzepatide |
Molecular Formula |
C₂₂₅H₃₄₈N₄₈O₆₈ |
Molecular Weight |
4813.53 Da |
Structural formula |
Y-Aib-Q-G-T-F-T-S-N-Y-S-I-amL-L-N-K(K17[AEEA-AEEA-γGlu-
GGSGGGSGGSGGRLIEDICLPRWGCLWEDD])-A-Q-Aib-A-F-I-E-Y-L-L-E-G-G-P-S-S-G-A-P-P-P-S-NH2
|
CAS Accession |
2023788-19-2 |
Size |
1mg, 5mg, 100mg, bulk |
Storage Condition |
Cool dry place(-20±5℃,Keep away from acids and alkali) |
Purity |
>98% |
Purification |
HPLC |
Endotoxin |
< 5 EU/mg |
Reconstitution Conditions |
Reconstitute in ddH₂O for a stock solution. |
Shipping Condition |
This product is shipped on ice packs. |
Note |
For Research Use Only! |